Donate

Testicular cancer strikes early.

It’s the most common cancer in men under 40.

Ben was diagnosed with testicular cancer at just 26. Three years after being given the all clear, he discovered another tumor on his remaining testicle.
Watch Ben's story
“I hadn’t been to the doctor in five years. I was 26 when the pain in my testicles started, when my fight with cancer started. You don’t want to wait. Everyone should go to the doctor.”
Hear Jonny's story

In most cases, the outcome for men with testicular cancer is positive, but a 95% chance of survival is no comfort to the 1 man in 20 who won’t make it.

When testicular cancer strikes, it strikes young. Most of those men are between 15 and 40 years old.

We have to help them, and stop men from dying too young.

We’ve spent years learning how to tackle the toughest cancer challenges in innovative ways. Now it's time to draw a line in the sand.

 

By 2030 we’ll halve the number of men dying from testicular cancer.

 

We’ll also halve the number of men facing serious ongoing side effects from testicular cancer treatment.

Help us get there.

Sign up for Movember
Make a donation
Spread the word
 
 

“Three years after my diagnosis, I’ve enjoyed my first year of marriage, run my first marathon, realised my dream to become a firefighter, and now I’m expecting my first child in November. I’m determined to never take a day for granted.”

Read Adam's story

This is how we’re going to win the fight.

Cancer research and care is full of difficult problems, but we’ve never been afraid of a challenge. We’ve spent years funding the most innovative and forward-thinking projects, getting the best researchers together to tackle the thorniest issues.
We’re focused on what works for men. From early detection through to diagnosis, treatment, and support: we’re not just looking for a cure. We’re looking for quality of life.

The plan of attack

1. Taking action early

Helping men know the signs, symptoms and risk factors for testicular cancer.

2. Bright minds brought together

We’re bringing the best minds from around the world together to collaborate.

3. Tackling biology

Increasing the knowledge of the most lethal prostate cancer tumours, and how to slow or stop its progression.

4. Reducing side effects

No matter where they are in the world, men and their families and carers must have access to services and support.

5. Affordable treatment

We’re influencing governments to provide affordable treatment and to get new treatments into practice faster.

6. Tailored treatments, precision care

Personalised treatment is the new frontier of cancer research. From distinguishing between harmless and lethal cancers, to taking into account genes, lifestyle and environment: it means a better outcome for men.

7. Helping men make tough choices

Men need the right info to understand their diagnosis and make an informed decision when it comes to treatment.

8. Raising the standard

We’re identifying excellence in testicular cancer treatment and care, to reduce the number of men who aren’t getting the best outcome possible.

9. Global initiatives

Our largest investment in testicular cancer is a global program that will mean better outcomes for men everywhere.
Download our investment strategy

We’ve funded more than 1,200 men’s health projects around the world. Here’s a snapshot of our work in testicular cancer.

Projects that span the globe

We link up researchers around the world and get results faster by encouraging collaboration. We share our successes and our failures, so the scientific community doesn’t waste time on duplicate research.

Global Action Plan

Our Global Action Plan (GAP) is an international research initiative that brings researchers together to tackle the toughest challenges in prostate and testicular cancer. Since GAP launched in 2011, it has formed 7 large-scale global initiatives supporting 350 researchers from 90 institutions across 21 countries.
Read more

Testicular Cancer Research Breakthrough

We funded the largest comprehensive sequencing study of testicular tumours published to date. This has lead to several ground-breaking discoveries that improve our understanding of testicular cancer and how to treat it effectively.
Read more
 
 

Dr Clare Turnbull

Clare is working to identify the genetics that increase a man’s risk of testicular cancer, and helping men assess their risk based on family history.
Hear more

Supporting the European contribution to the TIGER trial

We've partnered with the European Organisation for Research and Treatment of Cancer to fund a multi-national clinical trial to determine which therapy works best for men who've been treated for testicular cancer, but in whom the cancer has returned.
Read more

See all testicular cancer projects

It’s time we took action on testicular cancer.

A 95% chance of survival isn’t good enough, not for the 1 man in 20 who faces a lethal outcome, and not for us. Men are dying too young, and we need to help.

To get to where we want to be by 2030,
we need your help.

Sign up for Movember
Make a donation
Spread the word